In December 2024, staff at Vista Grande Villa, a nonprofit assisted living community in Jackson, Michigan, notified the adult sons of 85‑year‑old resident Marjorie Tingley that she had become a “major safety threat.” According to facility behavior logs, Tingley had multiple incidents in which she hit, kicked, or elbowed aides while being assisted with toileting, dressing, or bathing. The facility asked the family for permission to use sedating medications to control her behavior.
The sons alternately consented to and resisted medication recommendations. Records provided by the family and legal filings show that Vista Grande called emergency services repeatedly after altercations. Tingley was taken to emergency departments at least eight times. After several transfers and continuing disagreements about drug treatment, Vista Grande issued a 30‑day eviction notice. The family filed a lawsuit alleging negligence, emotional distress, wrongful eviction and asserting the facility initiated ER trips in retaliation for the family’s refusal to allow onsite medication. Vista Grande has denied the allegations and described the medications as “routine medication.” A negligence claim was dismissed on legal grounds; other claims remain pending.
Tingley died in January 2025. Medical records report the cause as plaque buildup in the brain, described in the source as a hallmark of Alzheimer’s disease.
Diseases that cause dementia damage brain regions that regulate impulse control and perception, which can lead to agitation and aggression. People with cognitive impairment may react with fear when they do not recognize caregivers or may use aggression as the only way to communicate pain, hunger, or discomfort. Long‑term care staff and other residents are commonly exposed to such altercations: federal inspection data and prior reporting cited in the source note frequent instances of resident‑to‑resident and resident‑staff incidents.
Memory care units and specialized assisted living settings typically serve populations with advanced cognitive impairment and often operate in locked units. These settings promise specialized staff and programming but also face challenges in managing behaviors without overreliance on sedating drugs.
The Centers for Medicare & Medicaid Services launched the Partnership to Improve Dementia Care in 2012 to target overprescribing of psychotropic medications in nursing homes. That initiative coincided with declines in antipsychotic use in nursing homes; nevertheless, inspector general reports and research highlighted in the source describe continuing and “alarming” instances of inappropriate antipsychotic use.
The Food and Drug Administration requires labels warning that certain antipsychotic drugs increase the risk of death in older adults with dementia‑related psychosis. Studies cited in the source estimate that a significant portion of Medicare beneficiaries with dementia—roughly one in four according to one JAMA estimate—are potentially inappropriately prescribed antipsychotics and other brain‑altering medications that can cause delirium, falls, and hospitalizations. Assisted living and memory care populations have shown variable prescribing patterns; a 2023 JAMDA study reported that residents with dementia were prescribed antipsychotics for about 13% of their time in assisted living on average.
Vista Grande’s records indicate that in early December 2024 staff began documenting behavioral incidents. The facility requested permission to medicate Tingley; the family asked for testing for a urinary tract infection (UTI), which they reported had caused prior agitation. The facility collected a urine sample but, per records the source reports, did not ensure it was tested by a lab for more than a week, necessitating repetition of the test.
In mid‑December, Vista Grande sent Tingley to Henry Ford Jackson Hospital for a psychiatric evaluation that could have led to involuntary hospitalization. Hospital psychiatrists did not find involuntary hospitalization necessary but did diagnose a urinary tract infection and treated it with antibiotics. According to hospital records cited by the source, the facility subsequently declared she could not return unless the family agreed to sedating medication.
The family ultimately allowed administration of Ativan (lorazepam) on an as‑needed basis. Ativan is a benzodiazepine rather than an antipsychotic; the source notes the drug was prescribed either by hospital clinicians or by a nurse practitioner affiliated with a medical group serving Vista Grande and other long‑term care settings. The facility had, according to the family, encouraged replacing the resident’s longtime physician with that medical group. The suit did not name the hospital, the medical group, or individual clinicians as defendants in the litigation described in the source.
Clinicians and experts quoted in the reporting emphasize that nonpharmacologic strategies—such as assessing for medical causes of agitation, preventing triggers, and tailored behavioral approaches—are preferable when possible. Still, geriatric psychiatrists acknowledge that severe behaviors sometimes necessitate medication.
The Tingleys’ lawsuit alleges negligence, emotional distress, wrongful eviction, and retaliatory initiation of ER transfers. Vista Grande denied these allegations and characterized the medications as routine and said it sent Tingley to the hospital because the family refused onsite treatment. A Michigan Circuit Court dismissed the negligence claim on legal grounds; remaining claims could go to trial if mediation fails. Vista Grande later became a subsidiary of Otterbein SeniorLife and was renamed; Otterbein is not named in the suit and did not respond to requests for comment in the reporting.
The case illustrates tensions families face when staff recommend psychotropic or sedating medications for agitation in dementia: consenting to medications may reduce immediate risk and ease caregiving burdens but carries known harms; refusing may lead to conflict with facilities that cite safety concerns and, in some cases, eviction. Assisted living and memory care facilities are state‑regulated and vary in clinical resources; unlike nursing homes, they typically do not provide continuous skilled medical care.
Federal efforts have reduced some antipsychotic use in nursing homes, but research and government reports cited in the source continue to document inappropriate prescribing and ongoing risk. The reporting emphasizes assessing reversible medical causes (for example, infection), prioritizing nonpharmacologic interventions, and recognizing that some severe behaviors may still require medication—decisions that families, clinicians, and facilities must weigh carefully.